Tag:
Wellcome Trust
Latest Headlines
Latest Headlines
Biotech venture rounds dwindle in Europe, tracking U.S. trend
Fresh on the heels of the news of a disappointing quarter for biotech investing in the U.S., Dow Jones VentureSource has done the math for Europe and come up with an equally dispiriting set of stats.
U.K. officials ready $286M fund to fuel a biotech revival
U.K. officials are preparing for the imminent launch of a $286 million fund designed to revive the country's biotech industry.
Wellcome joins chorus calling for free online access to medical research
Wellcome Trust no longer wants to pay for medical research that ends up guarded behind a pay wall.
Billions in new venture cash targeted at early-stage biotech efforts
The analysts at Burrill & Co. took out their calculators and concluded that $2.6 billion in new venture funds for translation and early-stage work materialized in the U.S. and Europe in the last two months.
New $317M biotech fund takes off at Wellcome Trust
The U.K's wealthiest charity has blueprinted big plans to back fledgling therapeutics and diagnostics companies with a brand new £200 million ($317 million) fund.
Court ruling could derail ambitious stem cell program for synthetic blood
A team of university researchers in the U.K. are working on an efficient formula for creating mass stocks of synthetic blood from stem cells. And they say may be just a couple of years from beginning
After three centuries, quinine no longer best for malaria
The largest-ever clinical trial in patients suffering from severe malaria--funded by the Wellcome Trust and published in The Lancet--is recommending that a 300-year-old treatment for the disease that
Wellcome Trust worries about immigration laws
The Wellcome Trust Sanger Institute is warning that the British coalition government’s recently imposed cap on immigration will have a negative impact on the the lab’s ability to produce
A PiggyBac ride to genetic causes of cancer
Researchers have developed a new genetic tool in mice to speed the discovery of novel genes involved in cancer. They're calling it PiggyBac, and it provides biological validation to human mutations
Merck venture to develop vaccines for the poor
Merck and Wellcome Trust have created the MSD Wellcome Trust Hilleman Laboratories, a not-for-profit R&D venture focused on affordable vaccines to prevent diseases common in low-income countries.
